Events
Regeneus Ltd is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.
California saw a 4.2 percent growth of jobs, about 12,500 in total, according to the latest report from the California Life Sciences Association.
Texas-based Pain Therapeutics is urging the FDA to reconsider the Complete Response Letter it issued in August for the company’s opioid-treatment, Remoxy. Representatives from Pain Therapeutics will meet with the FDA on Jan. 31. 2019 to discuss the request, the company announced late Monday.
Clinical data for a fish-oil-based drug from Amarin Corporation PLC confirmed the drug’s ability to reduce the relative risk reduction of adverse cardiovascular events by 25 percent, including a 20 percent reduction in cardiovascular death.
Ultragenyx Pharmaceutical Inc. today announced that it will host a conference call on Monday, November 5, 2018 at 5pm ET to discuss third quarter 2018 financial results and provide a corporate update.
Move part of effort to increase awareness and educate about preventive measures
Provepharm Life Solutions and partner Walter Reed Army Institute of Research were selected for project focusing on anti-malaria treatment in endemic regions
Microbiotica today announced that it will join the microbiome panel at this year’s BIO-Europe®, taking place in Copenhagen between 5-7 November.
Global campaign to support 125 million people worldwide highlights the seriousness of psoriasis and psoriatic arthritis.
The 11th EFIB attracted around 240 companies and stakeholders from 31 nations. EMBRIC joined the conference to speak about and highlight the potential of the blue biotechnology.
PRESS RELEASES